School of Pharmacy News & Media Center
The University of Mississippi

Pharmaceutics Students Excel in Receiving Internships

Posted on: March 23rd, 2022 by pmsmith
Tabish Mehraj and Abhishek Shettar

Tabish Mehraj and Abhishek Shettar

March 23, 2022

Five students from the Department of Pharmaceutics and Drug Delivery have received internships from leading industry companies and government agencies.

Michael Repka, chair and distinguished professor of the department and director of the Pii Center for Pharmaceutical Technology, praised the students for their efforts in attaining internships and noted this represents a significant increase for the department.

I have been our department chair for almost 17 years and this last year has shown a four-fold increase in our students receiving internships,” Repka said. “This fact definitely demonstrates the strength of the department and the high quality of our students.”

Tabish Mehraj, a fourth-year Ph.D. student, is in the process of an 18-month internship with the U.S. Food & Drug Administration where she will be working on a project funded by the agency’s Office of Women’s Health. The project will be located at the Center of Drug Evaluation and Research in Silver Spring, Maryland.

Sagar Narala, Praveen Kolimi and Zhiqing Hu

Sagar Narala, Praveen Kolimi and Zhiqing Hu

Third-year Ph.D. student Sagar Narala is interning with Bristol Myers Squibb as a co-op. His responsibilities will include analyzing raw materials and evaluating risk assessments associated with them, as well as media fingerprinting using various analytical techniques.

Zhiqing Hu, also a third-year Ph.D. student, is in a year-long internship with Biogen. During the internship, Hu will be working on small molecules development.

Third-year Ph.D. student Praveen Kolimi is in a six-month co-op program with Boehringer Ingelheim Pharmaceuticals. During the program, Kolimi will be focusing on drug metabolism and pharmacokinetics.

Abhishek Shettar, a third-year Ph.D. student, is interning with Continuus Pharmaceuticals, Inc. He will be working on the process and formulation development of new chemical entities in continuous manufacturing processes.